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Abstract
The world is undergoing a rapid health transition, with an ageing population and disease burden increasingly defined by
disability. In Sub-Saharan Africa the next 40 years are predicted to see reduced mortality, signalling a surge in the impact of
chronic diseases. We modelled these epidemiological changes and associated mental health workforce requirements. Years
lived with a disability (YLD) predictions for mental and substance use disorders for each decade from 2010 to 2050 for four
Sub-Saharan African regions were calculated using Global Burden of Disease 2010 study (GBD 2010) data and UN
population forecasts. Predicted mental health workforce requirements for 2010 and 2050, by region and for selected
countries, were modelled using GBD 2010 prevalence estimates and recommended packages of care and staffing ratios for
low- and middle-income countries, and compared to current staffing from the WHO Mental Health Atlas. Significant
population growth and ageing will result in an estimated 130% increase in the burden of mental and substance use
disorders in Sub-Saharan Africa by 2050, to 45 million YLDs. As a result, the required mental health workforce will increase
by 216,600 full time equivalent staff from 2010 to 2050, and far more compared to the existing workforce. The growth in
mental and substance use disorders by 2050 is likely to significantly affect health and productivity in Sub-Saharan Africa. To
reduce this burden, packages of care for key mental disorders should be provided through increasing the mental health
workforce towards targets outlined in this paper. This requires a shift from current practice in most African countries,
involving substantial investment in the training of primary care practitioners, supported by district based mental health
specialist teams using a task sharing model that mobilises local community resources, with the expansion of inpatient
psychiatric units based in district and regional general hospitals.
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Introduction
The recent Global Burden of Disease Study (GBD 2010) is the
largest systematic assessment of disease and injury-specific
epidemiology undertaken since its 1990 predecessor [1]. The
GBD methodology incorporates the years of life lost through
premature mortality (YLL) and years lived with disability (YLD)
into a single metric (the Disability Adjusted Life Year (DALY)).
Calculating disease burden worldwide and for 21 regions for 1990,
2005, and 2010 with methods to enable meaningful comparisons
over time, it has delivered much needed information and key
global health messages. The most notable of these is that the world
has undergone a rapid health transition over the 1990 to 2010
period – populations have aged, infectious and childhood diseases
are making way for non-communicable and chronic disorders, and
disease burden is increasingly defined by disability rather than
premature death [2].
The health transitions observed globally in GBD 2010 were not
as apparent across Sub-Saharan Africa (SSA). Improvements in
life-expectancies have trailed other regions, largely due to the
HIV/AIDS epidemic, maternal deaths, and child mortality caused
by infectious diseases and malnutrition. However these trends are
at a turning point and the next 40 years are predicted to see
significant reductions in child mortality and lowering mortality
from HIV/AIDS and malaria, signalling the inevitable health
transitions we have seen across the rest of the globe and a surge in
the impact of chronic and non-communicable diseases, defined by
long-term disability [3–6].
Mental and substance use disorders are the leading cause of
disability, accounting for 23% of all disability-associated burden
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(years lived with a disability, YLD) globally and 19% in Sub-
Saharan Africa in 2010 [7,8]. Major depressive disorder (MDD)
makes the largest contribution, accounting for approximately 40%
of YLDs in this group, yet the very limited mental health services
in Sub-Saharan Africa are frequently restricted to tertiary
psychiatric facilities treating those with acute psychoses, and to
humanitarian responses to traumatic events such as gender-based
violence and societal conflict [9].
For most, the idea of a non-communicable disease epidemic in
Sub-Saharan Africa may seem intangible, or at the very least, too
far off to contemplate – particularly given the fact that
communicable, maternal, neonatal and nutritional diseases still
account for approximately 68% of DALYs in the region [7]. So,
how imminent is this health transition, and what might it look like
for Sub-Saharan Africa? Using UN population data [10] and the
findings of GBD 2010, we estimate the change in burden of mental
and substance use disorders in context of the broader epidemi-
ological transition which will take place in Sub-Saharan Africa
from 2010 to 2050, and model the predicted increase in the mental
health workforce required to meet future needs.
Methods
GBD 2010
As part of the GBD 2010 study [4], burden of disease estimates
were produced for 20 mental and substance use disorders [8]. In
brief, this process consisted of systematic reviews for empirical
epidemiological data for each disorder as described by the
Diagnostic and Statistical Manual of Mental Disorders (DSM)
and/or the International Classification of Diseases (ICD) [11,12].
Internally consistent epidemiological models were created for each
disorder using DisMod-MR, a Bayesian meta-regression tool.
Adjustments to the data were made via various methods including
the application of covariates and severity distributions, and
comorbidity adjustments were applied to sequela-specific disability
weights in the calculation of YLDs (more detailed information can
be found in Murray et al 2012 [4] and Whiteford et al 2013 [8]).
For the GBD 2010, YLDs per person from a sequela (e.g. severe
major depression) are equal to the prevalence of the sequela
multiplied by the disability weight for the health state associated
with that sequela. YLDs for a disease or injury are the sum of the
YLDs for each sequela (e.g., mild, moderate and severe
depression) associated with the disease or injury [13].
Disability (YLD) estimates 2010 to 2050
YLD predictions for each 10-year period from 2010 to 2050
were calculated for the East, West, Central and Southern Sub-
Saharan African regions (as defined by the Global Burden of
Disease Study; refer to appendix S1 for a list of countries and
regions). We applied UN population data forecasts (see appendix
S1 for UN population data) to 2010 age-specific YLD rates
ascertained from the GBD 2010 to calculate changes in YLDs for
mental and substance use disorders in the context of communi-
cable (includes communicable, maternal, neonatal and nutritional
diseases) and non-communicable diseases for each Sub-Saharan
region and 10-year time period (see appendix S1 for full list of
mental and substance use disorders). By using 2010 YLD rates we
assume that age-specific prevalence and disability weights will
remain constant throughout the time period. It has been shown
that prevalence and disability weights are unlikely to change
Figure 1. Population age distribution in Sub-Saharan Africa, 2010 and 2050. Source: United Nations Population Data [36].
doi:10.1371/journal.pone.0110208.g001
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significantly over time for the majority of mental disorders;
however, there will likely be changes for substance use disorders
and the implications of this assumption are addressed in the
discussion [8].
Service requirements for 2010 and 2050
Recommended packages of care and service requirements in
low- and middle-income countries[14–16] formed the basis of
estimation methods of full time equivalent (FTE) staffing
requirements. Guided by the priority disorders identified in
Bruckner et al [14], 7 mental and substance use disorders which
were included in GBD 2010 were selected for modelling. Selected
disorders were schizophrenia, bipolar disorder, depression, alcohol
dependence disorder, opioid dependence disorder, conduct
disorder and attention deficit hyperactivity disorder (ADHD) (the
latter two for 5–19 year olds only). The seven disorders selected
are not intended to represent the only important conditions
(dementia and epilepsy are examples of other important conditions
that could be added to future modelling).
Prevalence estimates for 2010 and 2050
Disorder prevalence estimates are central to the estimation of
FTE staff requirements. The more recent prevalence estimates
from GBD 2010 were used over the prevalence estimates reported
in Bruckner et al. Pooled prevalence estimates for each disorder
and each of four Sub-Saharan Africa regions (East, West,
Southern and Central) were calculated using 2010 age and sex-
standardised prevalence estimates derived from DisMod-MR
modelling. Predicted pooled prevalence for 2050 was also
calculated using 2010 age and sex-standardised prevalence esti-
mates and UN population data for 2050 (see appendix S1 for UN
population figures). Pooled prevalence for the paediatric disorders
(ADHD and conduct disorder) were based on only prevalence
estimates from the 5–19 year age groups. Using similar methods,
pooled prevalence estimates for the entire Sub-Saharan Africa (4
regions) were also calculated. Prevalence estimates at the regional
level were applied to each country within that region.
Adjustments to prevalence estimates were necessary to account
for comorbidity between disorders. To allow for comorbidity
between depression, alcohol and opioid use disorders, the separate
and combined prevalence of MDD, alcohol use, alcohol depen-
dence, drug use and drug dependence were sourced from South
African survey data published by Williams et al [17]. The GBD
prevalence estimates for depression, alcohol and opioid use
disorders were reduced in proportion to their weighting relative
to the prevalence of any depressive or substance use disorder. This
was translated into the formula: (disorder prevalence divided by
sum of prevalences of individual depressive and substance use
disorders) multiplied by (prevalence of any depressive or substance
use disorder). Across the board, rates were adjusted down to
87.6% of the original total. This method was based on Lund et al
[18].
It was assumed that conduct disorder and ADHD held no
comorbidity with other disorders. However it was considered
implausible to assume no comorbidity in the model between
conduct disorder and ADHD. Data from the US National
Comorbidity Survey Replication – Adolescent [19] were therefore
used to estimate comorbidity between these childhood disorders,
as no African data were available. As per the method for
depressive and substance use disorders above, the raw prevalence
of ADHD, conduct and oppositional defiant disorders, as well as
the prevalence of any of these behavioural disorders, was used to
calculate a comorbidity weighting (prevalence/sum of individual
behavioural disorders) x (prevalence of any behavioural disorder).
The GBD prevalence rates for ADHD and conduct disorder were
adjusted down to 69.8% of the originals. A table summarising the
pooled prevalence of selected mental and substance use disorders
in Sub-Saharan Africa from GBD 2010, by region and adjusted
for comorbidity can be found in the appendix S1.
For the purpose of the modelling (and due to a lack of data to
estimate otherwise) it was assumed that bipolar disorder and
schizophrenia held no significant comorbidity with any other
mental disorders. Although these two disorders experience high
comorbidity with substance use disorders, it was considered that
the treatment patients would require for their substance use
disorder would be in addition to that for their bipolar disorder or
schizophrenia and therefore comorbidity adjustments were not
made. The implications of this are explored in the discussion.
Treatment packages
Treatment coverage targets and care packages (service coverage
and utilization rate for each type of service) for the priority
disorders were taken from Bruckner et al [14] (see appendix S1 for
more details). A slight modification to the Bruckner et al model
was made where an equivalent psychosocial treatment package as
that for alcohol use disorders was added for opioid use disorders in
line with WHO opioid treatment guidelines [20].
For each disorder, region or country and service type, the
number of bed-days for inpatient or residential or number of
sessions for outpatient care was equal to the population X adjusted
prevalence X treatment coverage target X service coverage X
utilisation rate, where: treatment coverage target is the percentage
of prevalent cases requiring or presenting for any treatment;
service coverage is the percentage of treated cases needing care in
this specific service setting in a year; and utilisation rate is the
average number of bed days used per case per year for cases
treated in inpatient services, or the average number of consulta-
tions or sessions per case per year for cases treated in outpatient
services.
Staffing ratios
Staffing ratios recommended by the mhGAP costing tool [16]
allowed estimation of staffing by health professional type –
psychiatrist, other physician/doctor, nurse, psychologist, other
psychosocial worker, and other provider/worker. The overall
‘nurse’ category was further split into psychiatric nurses and
general nurses using a ratio of 1:4, based on consultation with
African mental health experts in four countries (further field testing
is needed to validate this in future, as the figure will vary by
country and setting).
FTE staffing estimates by service type
FTE modelling was conducted for both 2010 and 2050, for each
of the four Sub-Saharan African regions and a small selection of
countries within each region. The selection of countries was done
without prejudice and merely as examples to highlight the stark
differences that can be observed across countries within the same
region. The countries selected for modelling FTE were: Sub-
Saharan Africa East – Zambia, Ethiopia, Burundi; Sub-Saharan
Africa West – Ghana, Nigeria, Chad; Sub-Saharan Africa Central
– Democratic Republic of Congo (DRC), Angola; Sub-Saharan
Africa Southern – South Africa, Zimbabwe.
For each region/country, the number of bed-days for inpatient/
residential services and sessions for outpatient services were
converted into FTE mental health staff requirements using the
following formulae. The number of FTE staff required to deliver
inpatient/residential mental health care was calculated as: number
of bed-days/0.85 (85% bed occupancy rate as per Bruckner et al)/365
Mental and Substance Use Disorders in Sub-Saharan Africa
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service days per annum/25 beds in unit x number of staff per unit
(7.5 per 25 beds as per mhGAP) x staffing ratio (proportion of
nurses, doctors, and other professionals in that setting from
mhGAP).
The number of FTE staff required to deliver outpatient mental
health care was calculated as: number of sessions/number of
consultations per day/240 working days per year (from mhGAP)
X staffing ratio (from mhGAP) [14,21]. Consultations per day
were derived from mhGAP as a weighted average across providers
in each category of outpatient care: outpatient care 28
consultations per day; primary care 29 consultations per day;
psychosocial (ancillary) care 27 consultations per day. Group day
programs were assumed to be delivered to an average of 10 users
per day.
Finally, gaps between the estimated target FTE staff for 2010
and the current mental health service FTE staffing levels in the




The population distribution in Sub-Saharan Africa is expected
to change dramatically over the next 40 years (Figure 1). An
expected doubling of population size from approximately 0.9
billion to 1.8 billion will be accompanied by a significant ageing.
As a result, a population dominated by under 25 s in 2010 (63%)
will be represented by over 25 s in 2050 (53%).
This change in demographics will result in a rapidly growing
disparity between the disability burden associated with communicable
compared to non-communicable diseases, with a one and a half fold
increase in non-communicable compared to communicable diseases
(Figure 2). Interestingly, although considering only population
ageing and growth would see communicable diseases experience a
doubling in burden, the burden in under 5 s – traditionally the most
important group for communicable diseases – could see only a
relatively modest increase over time of around 24% (appendix S1).
In terms of individual disorders, the largest contributor to
burden of disease is MDD (Figure 3). This is followed by
schizophrenia which is considered to be one of the most disabling
conditions across all diseases in GBD. The childhood disorders of
conduct disorder and ADHD will see relatively little increase in
burden as the populations of SSA ages significantly over the next
40 years.
In terms of mental and substance use disorders, all Sub-Saharan
African regions would experience an increase in burden of around
130% in the absence of a change in disorder prevalence rates
(Figure 4). This increase would vary across regions, with the
largest (196%) seen in Sub-Saharan Africa Central and the lowest
(28%) in Sub-Saharan Africa Southern (East = 139% and
West = 129%).
Mental and substance use disorders were the leading cause of
YLDs in Sub-Saharan Africa in 2010 (18.94% of total) and an
estimated rise from approximately 20 million YLDs to 45 million
YLDs could be experienced by 2050. Based on the individual
effects of demographic changes alone, by 2050 mental and
substance use disorders may be equivalent to approximately two
thirds the YLDs of the entire communicable diseases group (67
million YLDs, appendix S1).
Figure 2. Change in disability burden distribution of communicable and non-communicable diseases in Sub-Saharan Africa. Note:
CDs include all communicable, maternal, neonatal and nutritional diseases; NCDs include all non-communicable diseases (including mental and
substance use disorders).
doi:10.1371/journal.pone.0110208.g002
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Figure 3. Disability burden for individual mental and substance use disorders, 2010 to 2050.
doi:10.1371/journal.pone.0110208.g003
Figure 4. Disability burden of mental and substance use disorders in Sub-Saharan Africa over time, all ages.
doi:10.1371/journal.pone.0110208.g004
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Importantly, the shifting population distribution of Sub-Saharan
Africa seen in Figure 1 translates directly to the mental and
substance use burden changes seen in Figure 5, which shows the
increase in burden by age group. This is important for this group
of disorders, where the 20–54 age group is typically most affected.
Health service requirements
The overall predicted increase in target FTE per 100,000
population in each region from 2010 to 2050 is 24.0 to 24.3, due
to demographic changes influencing overall prevalence (Table 1).
This seemingly modest increase can be misleading though and
only when converted to absolute FTE do the estimates become
more meaningful in terms of health system planning. Target FTE
for Sub-Saharan Africa Southern in 2050 will increase by around
3,700 from the 2010 target, whilst the target FTE for Sub-Saharan
Africa East, a far more populous region, will need to increase by
95,400 over the 2010 to 2050 time period to meet the growth in
burden of disease.
Not only are there significant differences in target FTE increases
across the 4 regions, but also within the countries of each region
(Figure 6). The highly populous countries of Ethiopia, Nigeria and
DRC highlight well the impact of population growth and ageing
on health system requirements when compared against their
neighbouring countries. Nigeria is predicted to require an
additional 65,000 FTE staff to provide mental health care by
2050. In contrast, increases required in South Africa and
Zimbabwe are expected to be much smaller.
Perhaps more important than predicted increases in target FTE
is the gap between the estimated minimum FTE staffing
requirements for 2010 and the actual FTE staffing numbers that
currently exist within countries as reported by the WHO Mental
Health Atlas. The health challenges in Sub-Saharan Africa are
clearly demonstrated here with some countries reportedly having
only a fraction of current target staffing levels. Although current
FTE estimates from the WHO Mental Health Atlas and FTE
targets proposed in this paper are not strictly comparable across
the board, two groups of mental health workers, psychiatrists and
psychologists, can provide a reasonable indication of any shortfall
in mental health workers within a country (Table 2). Our estimates
highlight a very significant shortfall of mental health workers
across all SSA countries, with large variations within the same
geographical regions. Even South Africa, with clearly the best
mental health staffing capacity, appears to be lacking in crucial
areas such as numbers of psychiatrists. Particularly notable is
Nigeria, a country with low current capacity and one of the highest
predicted increases in requirements.
Discussion
We used UN population data to forecast the change in
disability-associated burden of seven of the major mental and
substance use disorders in Sub-Saharan Africa from 2010 to 2050.
It is estimated that during this 40 year period the population will
double in size and age significantly, making way for the dramatic
health transition seen in other regions of the world. Predictions
clearly highlight the anticipated shift from communicable diseases
characterised by high mortality to non-communicable diseases
with a chronic and disabling course.
Naturally, modelling burden estimates holding YLD rates
constant makes several assumptions, including that disorder
prevalence and disability weights remain constant. Whilst this is
entirely plausible for many non-communicable diseases, indeed
the prevalence of many mental disorders has been shown to not
change significantly over time [8], this may not be true for others.
Drug use disorder prevalence, for example, is expected to increase
in the Sub-Saharan Africa regions in the coming years, largely
driven by changing routes of drug trafficking [22,23].
Modelling changes in communicable diseases is also not straight
forward. Different factors are at play and will influence the
estimates. Firstly, the successes of public health campaigns such as
expanded programs on immunisation and insecticide treated nets
to combat malaria should continue to reduce the prevalence of
infectious diseases. Secondly, improvements in health systems and
treatments may not reduce the prevalence of some communicable
diseases but shift the burden from premature mortality to a more
chronic health loss; the push towards universal access to anti-
retroviral therapies makes HIV the definitive example of this and
will shape the future burden of disease in Sub-Saharan Africa
substantially. In terms of disability, it is possible that the gains
made by declines in prevalence of communicable, maternal,
neonatal and nutritional diseases over the next 40 years will be
partially offset by the increase in burden of chronic HIV.
Whatever the scenario for communicable disease may be, it is
clear that the balance in the contribution of communicable and
non-communicable diseases to disease burden is set to change
dramatically.
The consequences of a rising burden on non-communicable
disease (NCD) are far-reaching. For the mental and substance use
disorders, largest group of NCD’s the impacts are long-lasting at
the level of the individual, family and community [24]. Quality of
life is impacted and economic costs are significant. A recent study
estimates that the cumulative global impact of mental disorders
may amount to US$16 trillion of lost economic output over the
next 20 years, equivalent to 25% of global GDP in 2010 [25].
The secondary health outcomes of mental disorders also need to
be considered. For example, major depression has been shown to
be an independent risk factor for other important non-commu-
nicable disorders such as ischaemic heart disease [26] and a
consistent association between HIV and poor mental health has
been reported [27]. The strong and often bidirectional relation-
ships that exist between mental and substance use disorders with
communicable disease, non-communicable disease and injuries
emphasises the critical role of mental health [27].
Due to the pressures of communicable disease and malnutrition,
mental health in Africa has been low on the priority list to-date. In
terms of policy, a recent WHO report has revealed only 42.2% of
countries within the WHO Africa region report having a dedicated
mental health policy, 67% possess a mental health plan and 44%
report having dedicated mental health legislation [9]. African
countries reportedly spend less than 1% of their health budgets on
mental health [28].
As a result mental health services are poorly resourced and
generally accessible to only the most severely ill and then as
inpatients in urban facilities. Mental health care provided outside
the hospital by health and social workers based in the community
is only available in half of African countries [28]. Globally,
treatment rates for people with mental and substance use disorders
remain low [29,30], with treatment gaps over 90% in low and
middle income countries [29]. Perhaps an exception to this is in
traumatised populations where non-government organisations are
present, providing temporary mental health services during
emergency or post-conflict response efforts. However, these
services are not sustainable and it is important to prepare for
chronic disease and disability services beyond acute care.
In keeping with the recommendations of WHO, reaching FTE
targets set in this paper requires a shift from current practice in
most African countries, where psychiatric hospitals are the main
site of service delivery, and consume the vast majority of the
Mental and Substance Use Disorders in Sub-Saharan Africa
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country’s mental health budget [9]. Instead a new model is
required which involves substantial investment in the training of
primary care practitioners, supported by district based mental
health specialist teams, using a task sharing model that mobilises
local community resources [31,32]. The new model also requires
substantial investment in smaller inpatient psychiatric units, based
in district and regional general hospitals as reflected in the
inpatient services targets which demand the biggest increase in
resources in this model.
Health transitions in other regions of the world have been rapid
[4]. The health system reforms required to deal with dramatic
changes in burden of disease are intimidating and will take long
term careful planning. However the human and economic costs of
not preparing for this will be substantial. Sub-Saharan Africa is in
a particularly challenging position as it will soon be caught in the
rising tide of non-communicable disease, yet it still has a
considerable way to go in the fight against communicable,
maternal, neonatal and nutritional diseases. A logical starting
point in the preparation might be to implement packages of care
for key mental disorders which have been designed for low- and
middle-income countries and provide realistic goals given chal-
lenging environments such as those in Sub-Saharan Africa [21,33].
Fundamental in scaling up services is increasing the mental health
workforce [14] and integrating mental health into primary health
care [34,35]. A continuing commitment to addressing key research
priorities is also vital [34].
Limitations
As highlighted previously, this modelling is limited to disability-
associated burden only and makes the assumption of unchanged
disease prevalence and disability weights over time. Whilst this
may be a reasonable representation for the future of many non-
communicable diseases, changes in disease profiles of communi-
cable diseases will be likely. As mental and substance use disorders
are highly disabling conditions which carry a relatively small
amount of directly-associated mortality and there will be a future
shift to chronic, disabling diseases it was seen appropriate to
selectively present disability-associated burden forecasts.
One obvious omission from this paper which is particularly
relevant to the Sub-Saharan African context is that of neurological
disorders. Neurological disorders were modelled separately from
mental and substance use disorders in GBD 2010 and were not
included in our modelling. Given epidemiological transition and
ageing population, the inclusion of neurological disorders
(dementia in particular) would add substantially to the predicted
changes in burden and FTE requirements and have significant
implications for concomitant service requirements.
Other assumptions of our estimates are that predicted
demographic changes are correct. The estimation process of
mental disorder YLD rates ascertained in GBD 2010 additionally
carried some limitations which have been discussed elsewhere [8].
In particular, the lack of data from the Sub-Saharan region was
problematic and more epidemiological data is required from these
regions.
Comorbidity adjustments were not made between bipolar
disorder and schizophrenia and substance use disorders when
Figure 5. Change in disability burden of mental and substance use disorders over time, 20–54 years by age group, all Sub-Saharan
Africa.
doi:10.1371/journal.pone.0110208.g005
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the known comorbidity is high. There was no clear way to adjust
prevalence between these disorders in a way that would reflect the
reality of how service requirements would likely reduce (that is, a
reduction in substance use services) given the clinical reality that
any reduction in service requirements for a patient experiencing
bipolar disorder or schizophrenia and a substance use disorder
Figure 6. Predicted increase in FTE staff requirements for mental health care for selected Sub-Saharan African countries, 2010 to
2050. Note: SSA East – Zambia, Ethiopia, Burundi; SSA West – Ghana, Nigeria, Chad; SSA Central – DRC, Angola; SSA Southern – South Africa,
Zimbabwe.
doi:10.1371/journal.pone.0110208.g006
Table 2. Current and target 2010 FTE psychiatrists and psychologists per 100,000 population for selected countries in Sub-
Saharan Africa.
Country Psychiatrists Psychologists
Current 2010 target % target FTE Current 2010 target % target FTE
Sub-Saharan Africa East
Zambia 0.03 0.8 4% 0.02 0.3 7%
Ethiopia 0.04 0.8 5% 0.02 0.3 7%
Burundi 0.01 0.8 1% 0.01 0.3 3%
Sub-Saharan Africa West
Ghana 0.07 0.8 9% 0.04 0.3 13%
Nigeria 0.06 0.8 8% 0.02 0.3 7%
Chad 0.01 0.8 1% 0.01 0.3 3%
Sub-Saharan Africa Central
DRC 0.07 0.8 8% 0.015 0.3 5%
Angola 0.002 0.8 0.3% 0.003 0.3 1%
Sub-Saharan Africa Southern
South Africa 0.27 0.8 34% 0.31 0.3 103%
Zimbabwe 0.06 0.8 8% 0.04 0.3 13%
doi:10.1371/journal.pone.0110208.t002
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would be minimal given the very different packages of care,
intensity of treatment required and the low prevalence of these two
mental disorders. Although there is potential that treatment
services for substance use disorders have been overestimated to a
small degree, it should be noted that estimated staffing require-
ments for the treatment of opioid and alcohol use disorders will
likely be conservative due to using dependence (lower) prevalence
estimates, as provided by GBD 2010, with treatment targets and
care packages from Bruckner et al designed for the broader
category of abuse and dependence.
It is important to recognise that the model used for estimating
service requirements in this paper is one developed for both low-
and middle-income countries and may need substantial modifica-
tion to suit the Sub-Saharan African context. Furthermore, it is
recognised that each country will have its own health service and
workforce configuration and unique challenges, and therefore
targets should ideally be tailored to the country context.
Finally, the Mental Health Atlas only records mental health
labelled staff working in dedicated facilities/clinics whereas the
care packages presented by Bruckner and colleagues represent the
total package of care that person needs, including care that might
be provided by non-mental health specialists working in general
primary care clinics. These key differences make general
comparisons against the staffing targets modelled above difficult
yet the data is nonetheless informative.
Conclusion
With a rapid epidemiological transition predicted for Sub-
Saharan African over the coming decades it is now time to begin
planning for health services able to address a dramatic increase in
burden of non-communicable disease. Mental and substance use
disorders are already the leading cause of disability in Sub-
Saharan Africa yet services are drastically under-resourced.
Packages of care and service models advocating for a task shifting
approach and the embedding of mental health services within the
primary health care system are available for LMICs. Investment
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